. Author manuscript; available in PMC: 2010 Sep 22.

Published in final edited form as: Transplantation. 2008 Jul 15;86(1):75–81. doi: 10.1097/TP.0b013e31817352b9

TABLE 3.

De novo H-Y antibody development and histopathologic correlations in M→F patients with graft dysfunction

Patient characteristics (n=26 M→F)	H-Y antibody detected		P
Patient characteristics (n=26 M→F)	Yes (n=12)	No (n=14)	P
Biopsy assessment
AR	11 (92%)	3 (21%)	0.00048
Non-AR	1 (8%)	11 (79%)
C4d positive	1 (8%)	0 (0%)	NS
CD20⁺B cells	6 (50%)	3 (21%)	NS
CD138⁺/CD38⁺/plasma cells	8 (67%)	3 (21%)	0.04
Clinical assessment
Delayed graft function	5 (42%)	3 (21%)	NS
DSA positive	2 (17%)	5 (36%)	NS
Graft failure	1 (8%)	2 (14%)	NS
Time of biopsy (d), median (range)	724 (28–3386)	435 (33–3077)	NS